- 专利标题: CONTINUOUS CRYSTALLISATION METHOD
-
申请号: US17912646申请日: 2021-03-31
-
公开(公告)号: US20230133715A1公开(公告)日: 2023-05-04
- 发明人: Torfinn Haaland , Arne Askildsen , Heidi Kvande
- 申请人: GE Healthcare AS
- 申请人地址: NO Oslo
- 专利权人: GE Healthcare AS
- 当前专利权人: GE Healthcare AS
- 当前专利权人地址: NO Oslo
- 优先权: GB2004773.4 20200331
- 国际申请: PCT/EP2021/058529 WO 20210331
- 主分类号: C07C231/24
- IPC分类号: C07C231/24 ; C07C237/46
摘要:
The invention provides a method of purifying 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophathalamide, comprising adding a portion of acid to a stream comprising crude 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophathalamide in a solvent and continuously crystallising the 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophathalamide from the crude 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophathalamide, with removal of at least a fraction of the solvent, wherein the crystallisation is carried out in a continuous reactor, wherein the continuous reactor is a plug flow reactor. At least three further portions of acid are added to the continuous reactor during the crystallisation.
信息查询